When Kate Sheridan was 11 years old, a series of complications from Lyme Disease changed her life dramatically.
The FDA announced yesterday that it will permit marketing of Viz.ai’s Contact, a clinical decision support (CDS) tool that analyzes CT results and highlights cases that may have experienced a stroke.
Since his appointment in early 2017, U.S. Department of Veterans Affairs Secretary David Shulkin, MD, has made modernizing the agency a top priority. Shulkin has taken a number of steps to accomplish this, including the launch of the Anywhere to Anywhere initiative with President Trump in August 2017.
Digital diabetes care company Glooko announced today that its Mobile Insulin Dosing System (MIDS) — an app-driven tool that recommends insulin dose adjustments using data collected directly from a patient’s blood glucose meter — has been cleared by the FDA.
Portland, Oregon-based Bright.md, which makes a virtual physician's assistant app called SmartExam, has announced two new customer wins at Presbyterian Healthcare Services in New Mexico and Providence Health & Services in Oregon. Concurrent with the New Mexico launch, Bright.md has launched a Spanish-language version of the app as well.
Evidation Health just announced the launch of a 10,000 person chronic pain study, called the DisCover Project. The research aims to quantify chronic pain and develop digital biomarkers for chronic pain severity, flare ups and quality of life by using activity trackers, health apps, and other more traditional data points.
About the Author: @JohnGardner_VC has led and managed investments in companies across the information technology spectrum. He came to NGP Capital from BlueRun Ventures, where he was one of the founding partners.
Bensheim, Germany-based drug delivery system manufacturer Sanner GmbH and London, UK-based Amiko — a startup that has leveraged smart sensors and artificial intelligence to develop its connected inhaler and app suite Respiro — are looking to integrate novel technologies into medication packaging to better address the challenges of medication adherence.